Jahnke K - Search Results

1

Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma.

Korfel A, Martus P, Nowrousian MR, Hossfeld DK, Kirchen H, Brücher J, Stelljes M, Birkmann J, Peschel C, Pasold R, Fischer L, Jahnke K, Thiel E; German primary central nervous system lymphoma Study Group (G-PCNSL-SG). Korfel A, et al. Among authors: jahnke k. Br J Haematol. 2005 Jan;128(2):177-83. doi: 10.1111/j.1365-2141.2004.05284.x. Br J Haematol. 2005. PMID: 15638851 Free article. Clinical Trial.

2

Low-grade primary central nervous system lymphoma in immunocompetent patients.

Jahnke K, Thiel E, Schilling A, Herrlinger U, Weller M, Coupland SE, Krümpelmann U, Stein H, Korfel A. Jahnke K, et al. Br J Haematol. 2005 Mar;128(5):616-24. doi: 10.1111/j.1365-2141.2004.05361.x. Br J Haematol. 2005. PMID: 15725082 Free article.

3

Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system.

Jahnke K, Thiel E, Martus P, Schwartz S, Korfel A. Jahnke K, et al. Ann Hematol. 2006 Jan;85(1):45-50. doi: 10.1007/s00277-005-1096-3. Epub 2005 Aug 13. Ann Hematol. 2006. PMID: 16132909

4

Radiologic morphology of low-grade primary central nervous system lymphoma in immunocompetent patients.

Jahnke K, Schilling A, Heidenreich J, Stein H, Brock M, Thiel E, Korfel A. Jahnke K, et al. AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10):2446-54. AJNR Am J Neuroradiol. 2005. PMID: 16286384 Free PMC article.

5

International study on low-grade primary central nervous system lymphoma.

Jahnke K, Korfel A, O'Neill BP, Blay JY, Abrey LE, Martus P, Poortmans PM, Shenkier TN, Batchelor TT, Neuwelt EA, Raizer JJ, Schiff D, Pels H, Herrlinger U, Stein H, Thiel E. Jahnke K, et al. Ann Neurol. 2006 May;59(5):755-62. doi: 10.1002/ana.20804. Ann Neurol. 2006. PMID: 16586496

6

Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors.

Jahnke K, Thiel E, Martus P, Herrlinger U, Weller M, Fischer L, Korfel A; German Primary Central Nervous System Lymphoma Study Group. Jahnke K, et al. J Neurooncol. 2006 Nov;80(2):159-65. doi: 10.1007/s11060-006-9165-6. Epub 2006 May 13. J Neurooncol. 2006. PMID: 16699873

7

Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma.

Fischer L, Korfel A, Kiewe P, Neumann M, Jahnke K, Thiel E. Fischer L, et al. Among authors: jahnke k. Ann Hematol. 2009 Feb;88(2):133-9. doi: 10.1007/s00277-008-0575-8. Epub 2008 Aug 5. Ann Hematol. 2009. PMID: 18679681

8

Treatment options for central nervous system lymphomas in immunocompetent patients.

Jahnke K, Thiel E. Jahnke K, et al. Expert Rev Neurother. 2009 Oct;9(10):1497-509. doi: 10.1586/ern.09.100. Expert Rev Neurother. 2009. PMID: 19831839

9

High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma.

Jahnke K, Korfel A, Martus P, Weller M, Herrlinger U, Schmittel A, Fischer L, Thiel E; German Primary Central Nervous System Lymphoma Study Group (G-PCNSL-SG). Jahnke K, et al. Ann Oncol. 2005 Mar;16(3):445-9. doi: 10.1093/annonc/mdi075. Epub 2005 Jan 14. Ann Oncol. 2005. PMID: 15653703 Free article. Clinical Trial.

10

Prospective trial on topotecan salvage therapy in primary CNS lymphoma.

Fischer L, Thiel E, Klasen HA, Birkmann J, Jahnke K, Martus P, Korfel A. Fischer L, et al. Among authors: jahnke k. Ann Oncol. 2006 Jul;17(7):1141-5. doi: 10.1093/annonc/mdl070. Epub 2006 Apr 7. Ann Oncol. 2006. PMID: 16603598 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters